The ICD-9 to ICD-10 transition has not improved identification of rapidly progressing stage 3 and stage 4 chronic kidney disease patients: a diagnostic test study
Background The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney di...
Uložené v:
| Vydané v: | BMC nephrology Ročník 25; číslo 1; s. 55 - 8 |
|---|---|
| Hlavní autori: | , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
London
BioMed Central
14.02.2024
BioMed Central Ltd Springer Nature B.V BMC |
| Predmet: | |
| ISSN: | 1471-2369, 1471-2369 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | Background
The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD).
Patients and methods
Serial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients.
Results
5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%.
Conclusion
This research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%). |
|---|---|
| AbstractList | The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD). Serial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients. 5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%. This research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%). Background The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD). Patients and methods Serial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients. Results 5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%. Conclusion This research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%). Abstract Background The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD). Patients and methods Serial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients. Results 5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%. Conclusion This research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%). BackgroundThe International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD).Patients and methodsSerial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients.Results5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%.ConclusionThis research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%). Background The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD). Patients and methods Serial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients. Results 5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%. Conclusion This research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%). Keywords: Progression, CKD, ICD, Sensitivity, Specificity The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD).BACKGROUNDThe International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD).Serial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients.PATIENTS AND METHODSSerial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients.5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%.RESULTS5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%.This research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%).CONCLUSIONThis research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%). The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have poor accuracy, particularly in relation to rapidly progressing chronic kidney disease (CKD) patients. In 2016, the ICD system moved to revision 10. This study examines subjects in a large insurer database to determine the accuracy of ICD-10 CKD-staging codes to diagnose patients rapidly progressing towards end-stage kidney disease (ESKD). Serial observations of outpatient serum creatinine measurements from 2016 to 2021 of 315,903 patients were transformed to estimated glomerular filtration rate (eGFR) to identify CKD stage-3 and advanced patients diagnosed clinically (eGFR-CKD). CKD-staging codes from the same time period of 59,386 patients and used to identify stage-3 and advanced patients diagnosed by ICD-code (ICD-CKD). eGFR-CKD and ICD-CKD diagnostic accuracy was compared between a total of 334,610 patients. 5,618 patients qualified for the progression analysis; 72 were identified as eGFR rapid progressors; 718 had multiple codes to qualify as ICD rapid progressors. Sensitivity was 5.56%, with positive predictive value (PPV) 5.6%. 34,858 patients were diagnosed as eGFR-CKD stage-3 patients; 17,549 were also diagnosed as ICD-CKD stage-3 patients, for a sensitivity of 50.34%, with PPV of 58.71%. 4,069 patients reached eGFR-CKD stage-4 with 2,750 ICD-CKD stage-4 patients, giving a sensitivity of 67.58%, PPV of 42.43%. 959 patients reached eGFR-CKD stage-5 with 566 ICD-CKD stage-5 patients, giving a sensitivity of 59.02%, PPV of 35.85%. This research shows that recent ICD revisions have not improved identification of rapid progressors in diagnostic accuracy, although marked increases in sensitivity for stage-3 (50.34% vs. 24.68%), and PPV in stage-3 (58.71% vs. 40.08%), stage-4 (42.43% vs. 18.52%), and stage-5 (35.85% vs. 4.51%) were observed. However, sensitivity in stage-5 compares poorly (59.02% vs. 91.05%). |
| ArticleNumber | 55 |
| Audience | Academic |
| Author | Chang, Shirley Wu, Xiaoyan Jalal, Kabir Charest, Andre Quigg, Richard J. |
| Author_xml | – sequence: 1 givenname: Kabir surname: Jalal fullname: Jalal, Kabir email: kjalal@buffalo.edu organization: Department of Biostatistics, University at Buffalo, State University of New York – sequence: 2 givenname: Andre surname: Charest fullname: Charest, Andre organization: Division of Nephrology, Department of Medicine, University at Buffalo – sequence: 3 givenname: Xiaoyan surname: Wu fullname: Wu, Xiaoyan organization: Division of Nephrology, Department of Medicine, University at Buffalo – sequence: 4 givenname: Richard J. surname: Quigg fullname: Quigg, Richard J. organization: Division of Nephrology, Department of Medicine, University at Buffalo – sequence: 5 givenname: Shirley surname: Chang fullname: Chang, Shirley organization: Division of Nephrology, Department of Medicine, University at Buffalo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38355500$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu2zAQRYUiRfNof6CLgkA32SjlQ5SoborAfRkI0E26JkYUKTOVSZeUA_h3-qWd2G4SB0WgBYnhuZec0T0tjkIMtijeMnrBmKo_ZMaV4iXlVUlF1aiSvShOWNWwkou6PXq0Py5Oc76hlDWqoq-KY6GElJLSk-LP9cKS-exz2ZIpbjeMkilByH7yMZAFZBLiRPxyleKt7YnvbZi88wa259GRBCvfjxuCwJBszj4MJE8wWCIIhH6_r4hZpBi8Ib98H-yG9D5byJas0Agt80cCWIMhxDwhNdk8oXTdb14XLx2M2b7Zr2fFz69frmffy6sf3-azy6vS1FRNpYDWVabpnOSuAyWo7CqhKBMcekNbxbkEkJWTRllaW9o0ErgyomcgjKtrcVbMd759hBu9Sn4JaaMjeL0txDRoSPi00WqwrmPMcsG5qZywHTWgDOuE7JxpnECvTzuv1bpb2t5ggwnGA9PDk-AXeoi3mlFVK9q26HC-d0jx9xqHoZc-GzuOEGxcZ81b3nDGOaeIvn-C3sR1CjgrpGSt8E-31QM1AHbgg4t4sbkz1ZeN4hLdWo7UxX8o_Hq79Abz5zzWDwTvHnd63-K_iCHAd4BJMedk3T3CqL7Lsd7lWGOO9TbHmqFIPREZP20Th8_x4_NSsZNmvCcMNj1M4xnVXzTHBwU |
| CitedBy_id | crossref_primary_10_1186_s12882_024_03869_4 |
| Cites_doi | 10.1111/j.1475-6773.2005.00444.x 10.2307/2531595 10.1093/oxfordjournals.aje.a009804 10.1056/NEJMoa2102953 10.2215/CJN.04230510 10.2307/2529876 10.1681/ASN.2005020192 10.1371/journal.pone.0218919 10.3122/jabfm.2015.05.140136 10.1053/j.ajkd.2010.08.031 10.1111/imj.13729 10.1093/ndt/gfr598 10.1186/s12882-015-0194-2 10.2147/CLEP.S265619 10.1002/pds.5398 10.1186/s12882-018-0942-1 10.1186/s12882-019-1429-4 10.1161/01.STR.29.8.1602 10.1053/j.ajkd.2005.04.029 10.1186/1471-2369-14-81 10.1136/jamia.2009.001396 10.3390/life10120327 10.1371/journal.pone.0135834 10.1177/2333392820939801 10.1053/j.ajkd.2010.05.013 10.1007/s11255-017-1543-9 10.1111/j.1475-6773.2005.00482.x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
| DOI | 10.1186/s12882-024-03478-1 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Proquest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ (Directory of Open Access Journals) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1471-2369 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_aefb11e2322c4f3eb0ca8c1b35bfc7f3 PMC10868099 A782572192 38355500 10_1186_s12882_024_03478_1 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States New York United States--US |
| GeographicLocations_xml | – name: United States – name: New York – name: United States--US |
| GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QP 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI 7X8 5PM |
| ID | FETCH-LOGICAL-c608t-3a9f4c7bf52fba8305b4380132adc098225aa54f5c8e06e0775a28c3d1a3cf663 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001162448100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1471-2369 |
| IngestDate | Fri Oct 03 12:21:53 EDT 2025 Tue Nov 04 02:05:51 EST 2025 Thu Sep 04 20:14:57 EDT 2025 Thu Oct 09 21:51:27 EDT 2025 Tue Nov 11 11:12:47 EST 2025 Tue Nov 04 18:31:40 EST 2025 Wed Jul 23 01:46:33 EDT 2025 Sat Nov 29 03:42:20 EST 2025 Tue Nov 18 22:29:37 EST 2025 Sat Sep 06 07:22:09 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Progression Sensitivity Specificity ICD CKD |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c608t-3a9f4c7bf52fba8305b4380132adc098225aa54f5c8e06e0775a28c3d1a3cf663 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/aefb11e2322c4f3eb0ca8c1b35bfc7f3 |
| PMID | 38355500 |
| PQID | 2956855094 |
| PQPubID | 44769 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_aefb11e2322c4f3eb0ca8c1b35bfc7f3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10868099 proquest_miscellaneous_2927212220 proquest_journals_2956855094 gale_infotracmisc_A782572192 gale_infotracacademiconefile_A782572192 pubmed_primary_38355500 crossref_primary_10_1186_s12882_024_03478_1 crossref_citationtrail_10_1186_s12882_024_03478_1 springer_journals_10_1186_s12882_024_03478_1 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-02-14 |
| PublicationDateYYYYMMDD | 2024-02-14 |
| PublicationDate_xml | – month: 02 year: 2024 text: 2024-02-14 day: 14 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC nephrology |
| PublicationTitleAbbrev | BMC Nephrol |
| PublicationTitleAlternate | BMC Nephrol |
| PublicationYear | 2024 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | K Jalal (3478_CR3) 2019; 20 LA Inker (3478_CR16) 2021; 385 LB Goldstein (3478_CR6) 1998; 29 S Ko (3478_CR23) 2018; 48 HS Chase (3478_CR24) 2010; 17 SD Navaneethan (3478_CR29) 2011; 6 LA Stevens (3478_CR28) 2005; 16 CW Cipparone (3478_CR11) 2015; 28 J Davidson (3478_CR8) 2020; 12 ME Vlasschaert (3478_CR13) 2011; 57 3478_CR10 ME Grams (3478_CR14) 2011; 57 P Arora (3478_CR15) 2015; 16 ER DeLong (3478_CR21) 1988; 44 CH Tsai (3478_CR31) 2020; 10 JM Paik (3478_CR4) 2022; 31 NM Laird (3478_CR17) 1982; 38 3478_CR2 GK Robinson (3478_CR20) 1991; 6 KJ O’Malley (3478_CR1) 2005; 40 EF Kern (3478_CR27) 2006; 41 JL Fleet (3478_CR12) 2013; 14 RE Guevara (3478_CR7) 1999; 149 PE Ronksley (3478_CR25) 2012; 27 3478_CR26 J Lardon (3478_CR30) 2015; 210 3478_CR22 N McCormick (3478_CR9) 2015; 10 AS Go (3478_CR18) 2018; 19 F Cozzolino (3478_CR5) 2019; 14 P Arora (3478_CR19) 2017; 49 |
| References_xml | – volume: 40 start-page: 1620 issue: 5 Pt 2 year: 2005 ident: 3478_CR1 publication-title: Health Serv Res doi: 10.1111/j.1475-6773.2005.00444.x – volume: 44 start-page: 837 issue: 3 year: 1988 ident: 3478_CR21 publication-title: Biometrics doi: 10.2307/2531595 – volume: 149 start-page: 282 issue: 3 year: 1999 ident: 3478_CR7 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a009804 – volume: 385 start-page: 1737 issue: 19 year: 2021 ident: 3478_CR16 publication-title: N Engl J Med doi: 10.1056/NEJMoa2102953 – volume: 6 start-page: 40 issue: 1 year: 2011 ident: 3478_CR29 publication-title: Clin J Am Soc Nephrol doi: 10.2215/CJN.04230510 – volume: 38 start-page: 963 issue: 4 year: 1982 ident: 3478_CR17 publication-title: Biometrics doi: 10.2307/2529876 – volume: 210 start-page: 120 year: 2015 ident: 3478_CR30 publication-title: Stud Health Technol Inform – volume: 16 start-page: 2439 issue: 8 year: 2005 ident: 3478_CR28 publication-title: J Am Soc Nephrol doi: 10.1681/ASN.2005020192 – volume: 14 start-page: e0218919 issue: 7 year: 2019 ident: 3478_CR5 publication-title: PLoS ONE doi: 10.1371/journal.pone.0218919 – volume: 28 start-page: 678 issue: 5 year: 2015 ident: 3478_CR11 publication-title: J Am Board Fam Med doi: 10.3122/jabfm.2015.05.140136 – volume: 57 start-page: 29 issue: 1 year: 2011 ident: 3478_CR13 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2010.08.031 – ident: 3478_CR22 – volume: 48 start-page: 310 year: 2018 ident: 3478_CR23 publication-title: Intern Med J doi: 10.1111/imj.13729 – volume: 27 start-page: 1826 issue: 5 year: 2012 ident: 3478_CR25 publication-title: Nephrol Dial Transplant doi: 10.1093/ndt/gfr598 – ident: 3478_CR2 – volume: 16 start-page: 199 year: 2015 ident: 3478_CR15 publication-title: BMC Nephrol doi: 10.1186/s12882-015-0194-2 – volume: 12 start-page: 1095 year: 2020 ident: 3478_CR8 publication-title: Clin Epidemiol doi: 10.2147/CLEP.S265619 – volume: 31 start-page: 467 issue: 4 year: 2022 ident: 3478_CR4 publication-title: Pharmacoepidemiol Drug Saf doi: 10.1002/pds.5398 – volume: 19 start-page: 146 year: 2018 ident: 3478_CR18 publication-title: BMC Nephrol doi: 10.1186/s12882-018-0942-1 – volume: 20 start-page: 260 year: 2019 ident: 3478_CR3 publication-title: BMC Nephrol doi: 10.1186/s12882-019-1429-4 – volume: 29 start-page: 1602 year: 1998 ident: 3478_CR6 publication-title: Stroke doi: 10.1161/01.STR.29.8.1602 – ident: 3478_CR26 doi: 10.1053/j.ajkd.2005.04.029 – volume: 14 start-page: 81 year: 2013 ident: 3478_CR12 publication-title: BMC Nephrol doi: 10.1186/1471-2369-14-81 – volume: 17 start-page: 588 issue: 5 year: 2010 ident: 3478_CR24 publication-title: J Am Med Inform Assoc doi: 10.1136/jamia.2009.001396 – volume: 10 start-page: 327 issue: 12 year: 2020 ident: 3478_CR31 publication-title: Life (Basel) doi: 10.3390/life10120327 – volume: 10 start-page: e0135834 issue: 8 year: 2015 ident: 3478_CR9 publication-title: PLoS ONE doi: 10.1371/journal.pone.0135834 – volume: 6 start-page: 15 issue: 1 year: 1991 ident: 3478_CR20 publication-title: Stat Sci – ident: 3478_CR10 doi: 10.1177/2333392820939801 – volume: 57 start-page: 44 issue: 1 year: 2011 ident: 3478_CR14 publication-title: Am J Kidney Dis doi: 10.1053/j.ajkd.2010.05.013 – volume: 49 start-page: 1033 issue: 6 year: 2017 ident: 3478_CR19 publication-title: Int Urol Nephrol doi: 10.1007/s11255-017-1543-9 – volume: 41 start-page: 564 issue: 2 year: 2006 ident: 3478_CR27 publication-title: Health Serv Res doi: 10.1111/j.1475-6773.2005.00482.x |
| SSID | ssj0017840 |
| Score | 2.3381417 |
| Snippet | Background
The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology... The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes.... Background The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology... BackgroundThe International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology... Abstract Background The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 55 |
| SubjectTerms | Accuracy Chronic kidney failure CKD Classification Comorbidity Creatinine Diabetes Diagnosis Diagnostic Tests, Routine End-stage renal disease Epidemiology Epidermal growth factor receptors Glomerular Filtration Rate Heart Humans Hypertension ICD Internal Medicine International Classification of Diseases Kidney diseases Kidney Failure, Chronic - diagnosis Kidney Failure, Chronic - epidemiology Medicine Medicine & Public Health Nephrology Patients Progression Regression analysis Renal Insufficiency, Chronic - diagnosis Renal Insufficiency, Chronic - epidemiology Sensitivity Specificity |
| SummonAdditionalLinks | – databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtQwFLVgihAb3o9AQUZCYgHRxHGScdigUqioRKtZACory_FjGlElwyRF6u_wpdzreKakiK7YRbE9sjMnx_fGx8eEvMCEsEyViRnjJs6sdrFArStn0G1W2kJ7yf_XT7PDQ3F0VM7D9uguyCrXnOiJenB7Rt02kPDUtBq_mE9T3OWWo_nb2-WPGM-QwrXWcKDGVbKFxlvJhGzN9w_m3zarCjPIZtYbZ0Qx7YCbIb6EWSpOeIbZ1Ghy8h7-fzP1H1PVRRnlhbVUP0Xt3fq_g7tNboZQle4M2LpDrtjmLrl-EBbj75FfADG6v_s-Lmnf-guW0B7nPi8Do8eqo03b09p_t7CG1iZIkzwaaOvoSi1rc3JGvUoMBbnNgkK4urCUU9WYcJ1RPVj40u-1aewZDatKNJjCdm-ognteMwh9pRA999T75t4nX_Y-fN79GIcjH2JdJKKPuSpdpmeVy1NXKQFkVKElPqTMyugEvQZzpfLM5VrYpLDo36dSoblhimsH0dMDMmnaxj4i1Bo0E3SFc8pl1hk1Y8xC-FNqA0lSziLC1v-11MEPHY_lOJE-LxKFHPAhAR_S40NCm1ebNsvBDeTS2u8QQpua6OTtb7SrhQzEIJV1FXQMAttUZ47bKtFKaFbxvHJ65nhEXiIAJfINdE-rsG0CBonOXXIHQrwc0vgyjcj2qCbwhB4Xr7EnA0918hxqEXm-KcaWqL1rbHuKdVL4AYgjk4g8HBC_GRKHAB6aQ4kYvQujMY9LmvrYu5jjEV8C8pOIvF6_Nuf9-vdDfXz5MJ6QG6l_odOYZdtk0q9O7VNyTf_s6271LBDCbwEFb_Y priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELagIMQL9xEoaJCQeICIOE6yDm-lUIEEFRJQ9c1yfLQRVVJtUqT-HX4pM15nIeWQ4C2KZ1ZjZzzHzvgzY48pIaxzbVPOhU0LZ3wqqddVcBSb164yoeV_791id1fu79cf4qGwYep2n0qSwVKHbS2r5wNaUowG0aekmSgo9znPLpSENkM5-se9de1ggTnLdDzmt3wzFxSQ-n-1xz85pLPNkmcqpsER7Vz9vylcY1di4AlbK025zs657ga79D6W1m-yb6gw8Hb7VVrD2IcHnsFIniw0dcGhHqDrR2jDvxDOQmtjo1H4ttB7WOrj1h6dQuj5ovba7gAw-DxwIEB3Nj4XYFaAvPCltZ07hVgjggjxOrwAje9CByDKChgLjxBQcG-xzzuvP22_SeMFDqmpMjmmQte-MIvGl7lvtETT0hDAPSbA2pqMkANLrcvCl0a6rHKExqdzaYTlWhiPsdBtttH1nbvLwFmCBvSV99oXzlu94NxhMFMbiylPyRPGp2-qTEQ3p0s2jlTIcmSlVouvcPFVWHyFPE_XPMcrbI-_Ur8kVVlTEi53eNEvD1Tc5ko736BgGKbmpvDCNZnR0vBGlI03Cy8S9oQUTZH1QPGMjocgcJKEw6W2MGArMSmv84Rtzihx15v58KSqKlqdQeV09rMkSMSEPVoPEyd10nWuPyGaHH8Ao8IsYXdWmr2eksBwHNlxRM50fjbn-UjXHgZMcrqwS2K2kbBnk-r_kOvPi3rv38jvs8t52D15yotNtjEuT9wDdtF8Hdth-TCYge9_XVkQ priority: 102 providerName: Springer Nature |
| Title | The ICD-9 to ICD-10 transition has not improved identification of rapidly progressing stage 3 and stage 4 chronic kidney disease patients: a diagnostic test study |
| URI | https://link.springer.com/article/10.1186/s12882-024-03478-1 https://www.ncbi.nlm.nih.gov/pubmed/38355500 https://www.proquest.com/docview/2956855094 https://www.proquest.com/docview/2927212220 https://pubmed.ncbi.nlm.nih.gov/PMC10868099 https://doaj.org/article/aefb11e2322c4f3eb0ca8c1b35bfc7f3 |
| Volume | 25 |
| WOSCitedRecordID | wos001162448100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: RBZ dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: M~E dateStart: 20000101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central (New) customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1471-2369 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017840 issn: 1471-2369 databaseCode: RSV dateStart: 20001201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagIMQF8SyBshokJA4QNc7T4daWVlSiq1WBqpwsx482ospWuylS_w6_lBnHu3SLgAuXKIntaOwZzyMef2bsFQWEdapMzHlm4txqFwvKdc04ks1rW2qf8n_0sRqPxfFxPbly1BflhA3wwMPAbSrrGs4tGv5U5y6zTaKV0LzJisbpynmcz6SqF8FUWD-oMG5ZbJER5eYctTB6kmiP4iTLKW5aMUMerf93nXzFKF1PmLy2auqN0d59di94kbA1UP-A3bDdQ3bnIKyTP2I_kPuwv_M-rqGf-hueQE9myWdowamaQzftofW_FKyB1oSsIc8omDqYqfPWnF2CT-CiXNnuBNCTPLGQgepMuM9BD-i68K01nb2EsOADAa91_g4UvvPpfEgroGPbg4e0fcy-7O1-3vkQh9MYYl0moo8zVbtcV40rUtcogXqiIbR6jGaV0QnBABZKFbkrtLBJaQlaT6VCZ4arTDt0bJ6wtW7a2acMrCGcP1c6p1xunVEVchg9k1objF8KHjG-YI7UAaqcTsw4kz5kEaUcGCqRodIzVGKbN8s25wNQx19rbxPPlzUJZNu_QNGTQfTkv0QvYq9JYiSpAiRPq7CjATtJoFpyC72vAiPsOo3YxkpNnMJ6tXghczKokLlMaSNnQfiGEXu5LKaWlBbX2ekF1UnxA-jiJRFbH0R02aUMfWtsjiViRXhX-rxa0rWnHmCcTt8SGDpE7O1Czn_R9edBffY_BvU5u5v6eZrGPN9ga_3swr5gt_X3vp3PRuxmdVz5qxixW9u748nhyM98fJrsH0y-4tPhp6OfTKRc2A |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLbKFAEX9iVQwEggDhA1-4KEUGmpOurMaA4FlZNxvEwjqmSYpKD5O_wAfiPvOcmUFNFbD9yi2I7s5Htb_Pw9Qp5jQJh6XNqu60s7UELbCea6-i5M201VJEzK_6dRPJkkh4fpdI386s7CYFplpxONopalwH_kmx6eawuR7u3d_JuNVaNwd7UrodHAYl8tf0DIVr0d7sD3feF5ux8OtvfstqqALSInqW2fpzoQcaZDT2c8AbxnyLoOURmXwkE6u5DzMNChSJQTKaSI414ifOlyX2gw0PDcS2Q9ALA7A7I-HY6nn1f7FjHES93RnCTarED7gwcLdtB2_ADjtZ75M1UC_rYFfxjDs4maZ3ZrjRHcvfG_vb6b5HrrbtOtRj5ukTVV3CZXxm1CwR3yE8SEDrd37JTWpblwHVqj_TapbPSIV7Qoa5qbfy9K0ly26VUG0bTUdMHnuTxeUpPphknFxYyCyz1T1Ke8kO11QEVDQ0y_5rJQS9rujNGW2LZ6QzncM3mPMFcKEUBNDffvXfLxQt7QPTIoykI9IFRJJETUkdZcB0pLHruuAhcuFRICvdC1iNuhiYmW0x1LixwzE9slEWsQyACBzCCQwZhXqzHzhtHk3N7vEaSrnshGbm6UixlrlRvjSmcwMXDOPRFoX2WO4IlwMz_MtIi1b5GXCHGGOhOmJ3h79AMWiexjbAvc1DAG2-lZZKPXE3Sd6Dd36Gatrq3YKbQt8mzVjCMxf7BQ5Qn28eAB4As7FrnfyNRqST4EITAcWpKetPXW3G8p8iPDxI5lyhKIsSzyuhPM03n9-6U-PH8ZT8nVvYPxiI2Gk_1H5Jpn1Idnu8EGGdSLE_WYXBbf67xaPGnVDyVfLlpkfwP76MD3 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagoIqXctNAASMh8QBR4zjJOryVlhUVZVVxVH2zHB_biCpZ7aZI_Tv8UmYc79KUQ0K8RfF4ZTvjOdbffCbkOSaEZapMzBg3cWa1iwViXTmDYbPSFtpD_o8ORpOJOD4uDy9U8Xu0-_JIsq9pQJamptueGddvcVFsL8CqQmQI_iVOeIZ50FVyLYNMBkFdHz8drc4RRpC_LEtlfttv4I48a_-vtvmCc7oMnLx0euqd0vjm_0_nFtkIASnd6TXoNrlimztk_UM4cr9LvoMi0f3dvbikXesfWEI79HAe7EVP1II2bUdr_--ENbQ2AYDkvzltHZ2rWW1Oz6nHgiHstplSCEqnlnKqGhOeM6p7ol76tTaNPafh7IgG6tfFa6rgnUcGwlgpxMgd9ey498iX8dvPu-_icLFDrItEdDFXpcv0qHJ56iolwORUSHwPibEyOkFGwVypPHO5FjYpLLL0qVRobpji2kGMdJ-sNW1jNwm1BikDXeGccpl1Ro0YsxDklNpAKpSziLDl95U6sJ7j5Run0mc_opD94ktYfOkXX0Kfl6s-s57z46_Sb1BtVpLI1-1ftPOpDNtfKusqGBiEr6nOHLdVopXQrOJ55fTI8Yi8QKWTaFVgeFqF4giYJPJzyR0I5HJI1ss0IlsDSbAGeti8VFsZrNFCplgTmiNVYkSerZqxJyLsGtueoUwKPwDRYhKRB72Wr6bEIUyH7tAiBvo_mPOwpalPPFc5XuQlIAuJyKvlNvg5rj8v6sN_E39K1g_3xvJgf_L-EbmR-o2UxizbImvd_Mw-Jtf1t65ezJ946_ADtPdk2A |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+ICD-9+to+ICD-10+transition+has+not+improved+identification+of+rapidly+progressing+stage+3+and+stage+4+chronic+kidney+disease+patients%3A+a+diagnostic+test+study&rft.jtitle=BMC+nephrology&rft.au=Jalal%2C+Kabir&rft.au=Charest%2C+Andre&rft.au=Wu%2C+Xiaoyan&rft.au=Quigg%2C+Richard+J&rft.date=2024-02-14&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2369&rft.eissn=1471-2369&rft.volume=25&rft.issue=1&rft_id=info:doi/10.1186%2Fs12882-024-03478-1&rft.externalDocID=A782572192 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2369&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2369&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2369&client=summon |